Purinoceptors in inflammation: Potential as anti-inflammatory therapeutic targets

Frontiers in Bioscience

Volumn 16, Issue 6, 2011, Pages 2172-2186

  Ferrero, Maria Elena ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adenosine Receptors; Inflammation; P2X receptors; P2Y Receptors; Purinoceptors; Review

Indexed keywords

MAMMALIA;

PURINERGIC RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL; BIOLOGICAL MODEL; DRUG EFFECT; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NEUROIMMUNOMODULATION; PAIN; PURINERGIC ANTAGONISTS; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION;

EID: 79959739650     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3846     Document Type: Review

References (162)

1. G. Burnstock, B. B. Fredholm, R. A. North and A. Verkhratsky: The birth and postnatal development of purinergic signalling. Acta Physiol (Oxf), 199(2), 93-147 (2010)
2. A. N. Drury: The physiological activity of nucleic acid and its derivatives. Physiological Reviews, 16, 33 (1936)
3. A. N. Drury and A. Szent-Gyorgyi: The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol, 68(3), 213-37 (1929)
4. F. A. Richards: The effect of adenylic acid and adenosine on the human heart and blood vessels. J Physiol, 81 (1934)
5. R. M. Honey, W. T. Ritchie and W. A. R. Thomson: The action of adenosine upon the human heart. QJM, OS-23, 5 (1930)
6. J. H. Gillespie: The biological significance of the linkages in adenosine triphosphoric acid. J Physiol, 80(4), 345-59 (1934)
7. D. T. Watts: Stimulation of uterine muscle by adenosine triphosphate. Am J Physiol, 173(2), 291-6 (1953)
8. G. Burnstock, B. Dumsday and A. Smythe: Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol, 44(3), 451-61 (1972)
9. G. Burnstock: Purinergic nerves. Pharmacological Reviews, 24(3), 509-81 (1972)
10. G. Burnstock: Purinergic signalling: past, present and future. Brazilian Journal of Medical & Biological Research, 42(1), 3-8 (2009)
11. G. Burnstock and A. Verkhratsky: Long term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death and Disease, 1 (2010)
12. J. T. Neary and H. Zimmermann: Trophic functions of nucleotides in the central nervous system. Trends in Neurosciences, 32(4), 189-98 (2009)
13. M. P. Mahaut-Smith, G. Tolhurst and R. J. Evans: Emerging roles for P2X1 receptors in platelet activation. Platelets, 15(3), 131-44 (2004) (Pubitemid 38651025)
14. P. E. van der Meijden, M. A. Feijge, P. L. Giesen, M. Huijberts, L. P. van Raak and J. W. Heemskerk: Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thrombosis & Haemostasis, 93(6), 1128-36 (2005) (Pubitemid 40823519)
15. I. R. Orriss, G. Burnstock and T. R. Arnett: Purinergic signalling and bone remodelling. Curr Opin Pharmacol, 10(3), 322-30 (2010)
16. G. D. Housley, A. Bringmann and A. Reichenbach: Purinergic signaling in special senses. Trends in Neurosciences, 32(3), 128-41 (2009)
17. D. Erlinge and G. Burnstock: P2 receptors in cardiovascular regulation and disease. Purinergic Signal, 4(1), 1-20 (2008)
18. B. B. Fredholm, M. P. Abbracchio, G. Burnstock, J. W. Daly, T. K. Harden, K. A. Jacobson, P. Leff and M. Williams: Nomenclature and classification of purinoceptors. Pharmacological Reviews, 46(2), 143-56 (1994) (Pubitemid 24984777)
19. R. A. North: Molecular physiology of P2X receptors. Physiological Reviews, 82(4), 1013-67 (2002)
20. M. P. Abbracchio, G. Burnstock, J. M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson and G. A. Weisman: International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacological Reviews, 58(3), 281-341 (2006) (Pubitemid 44394905)
21. V. Ralevic and G. Burnstock: Receptors for purines and pyrimidines. Pharmacological Reviews, 50(3), 413-92 (1998) (Pubitemid 28477681)
22. M. L. Trincavelli, S. Daniele and C. Martini: Adenosine receptors: what we know and what we are learning. Curr Top Med Chem, 10(9), 860-77 (2010)
23. H. Piirainen, Y. Ashok, R. T. Nanekar and V. P. Jaakola: Structural features of adenosine receptors: From crystal to function. Biochim Biophys Acta (2010)
24. J. N. Yang, J. F. Chen and B. B. Fredholm: Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. Am J Physiol Heart Circ Physiol, 296(4), H1141-9 (2009)
25. M. Fornai, L. Antonioli, R. Colucci, N. Ghisu, P. Buccianti, A. Marioni, M. Chiarugi, M. Tuccori, C. Blandizzi and M. Del Tacca: A1 and A2a receptors mediate inhibitory effects of adenosine on the motor activity ofhuman colon. Neurogastroenterology & Motility, 21(4), 451-66 (2009)
26. J. W. Daly, R. F. Bruns and S. H. Snyder: Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. Life Sci, 28(19), 2083-97 (1981) (Pubitemid 11089601)
27. A. M. Sebastiao and J. A. Ribeiro: Adenosine receptors and the central nervous system. Handb Exp Pharmacol(193), 471-534 (2009)
28. T. W. Stone, S. Ceruti and M. P. Abbracchio: Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Handb Exp Pharmacol(193), 535-87 (2009)
29. D. Yang, H. Chen, M. Koupenova, S. H. Carroll, A. Eliades, J. E. Freedman, P. Toselli and K. Ravid: A new role for the A2b adenosine receptor in regulating platelet function. J Thromb Haemost, 8(4), 817-27 (2010)
30. H. K. Eltzschig, J. Rivera-Nieves and S. P. Colgan: Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin Ther Targets, 13(11), 1267-77 (2009)
31. O. Bjorklund, M. Shang, I. Tonazzini, E. Dare and B. B. Fredholm: Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage. Eur J Pharmacol, 596(1-3), 6-13 (2008)
32. Y. Inoue, H. Tanaka, Y. Sumi, T. Woehrle, Y. Chen, M. I. Hirsh and W. G. Junger: A3 Adenosine Receptor Inhibition Improves the Efficacy of Hypertonic Saline Resuscitation. Shock (2010)
33. G. Burnstock and C. Kennedy: Is there a basis for distinguishing two types of P2-purinoceptor? General Pharmacology, 16(5), 433-40 (1985) (Pubitemid 16250911)
34. T. Kawate, J. C. Michel, W. T. Birdsong and E. Gouaux: Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature, 460(7255), 592-8 (2009)
35. L. E. Browne, L. H. Jiang and R. A. North: New structure enlivens interest in P2X receptors. Trends Pharmacol Sci, 31(5), 229-37 (2010)
36. K. Mulryan, D. P. Gitterman, C. J. Lewis, C. Vial, B. J. Leckie, A. L. Cobb, J. E. Brown, E. C. Conley, G. Buell, C. A. Pritchard and R. J. Evans: Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature, 403(6765), 86-9 (2000) (Pubitemid 30038526)
37. E. W. Inscho, A. K. Cook, J. D. Imig, C. Vial and R. J. Evans: Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest, 112(12), 1895-905 (2003) (Pubitemid 38063713)
38. C. Lecut, K. Frederix, D. M. Johnson, C. Deroanne, M. Thiry, C. Faccinetto, R. Maree, R. J. Evans, P. G. Volders, V. Bours and C. Oury: P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation. J Immunol, 183(4), 2801-9 (2009)
39. T. Woehrle, L. Yip, A. Elkhal, Y. Sumi, Y. Chen, Y. Yao, P. A. Insel and W. G. Junger: Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T cell activation at the immune synapse. Blood (2010)
40. A. R. Ase, L. P. Bernier, D. Blais, Y. Pankratov and P. Seguela: Modulation of heteromeric P2X1/5 receptors by phosphoinositides in astrocytes depends on the P2X1 subunit. J Neurochem, 113(6), 1676-84 (2010)
41. M. I. Harhun, O. V. Povstyan and D. V. Gordienko: Purinoreceptor-mediated current in myocytes from renal resistance arteries. Br J Pharmacol, 160(4), 987-97 (2010)
42. J. Ren, X. Bian, M. DeVries, B. Schnegelsberg, D. A. Cockayne, A. P. Ford and J. J. Galligan: P2X2 subunits contribute to fast synaptic excitation in myenteric neurons of the mouse small intestine. J Physiol, 552(Pt 3), 809-21 (2003) (Pubitemid 37428422)
43. M. Prasad, I. M. Fearon, M. Zhang, M. Laing, C. Vollmer and C. A. Nurse: Expression of P2X2 and P2X3 receptor subunits in rat carotid body afferent neurones: role in chemosensory signalling. J Physiol, 537(Pt 3), 667-77 (2001) (Pubitemid 34026599)
44. W. Rong, A. V. Gourine, D. A. Cockayne, Z. Xiang, A. P. Ford, K. M. Spyer and G. Burnstock: Pivotal role of nucleotide P2X2 receptor subunit of the ATP-gated ion channel mediating ventilatory responses to hypoxia. J Neurosci, 23(36), 11315-21 (2003) (Pubitemid 37549687)
45. T. E. Finger, V. Danilova, J. Barrows, D. L. Bartel, A. J. Vigers, L. Stone, G. Hellekant and S. C. Kinnamon: ATP signaling is crucial for communication from taste buds to gustatory nerves. Science, 310(5753), 1495-9 (2005) (Pubitemid 41746346)
46. D. A. Cockayne, S. G. Hamilton, Q. M. Zhu, P. M. Dunn, Y. Zhong, S. Novakovic, A. B. Malmberg, G. Cain, A. Berson, L. Kassotakis, L. Hedley, W. G. Lachnit, G. Burnstock, S. B. McMahon and A. P. Ford: Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature, 407(6807), 1011-5 (2000)
47. X. Bian, J. Ren, M. DeVries, B. Schnegelsberg, D. A. Cockayne, A. P. Ford and J. J. Galligan: Peristalsis is impaired in the small intestine of mice lacking the P2X3 subunit. J Physiol, 551(Pt 1), 309-22 (2003) (Pubitemid 37062931)
48. J. A. Sim, S. Chaumont, J. Jo, L. Ulmann, M. T. Young, K. Cho, G. Buell, R. A. North and F. Rassendren: Altered hippocampal synaptic potentiation in P2X4 knockout mice. J Neurosci, 26(35), 9006-9 (2006) (Pubitemid 44319390)
49. K. Yamamoto, T. Sokabe, T. Matsumoto, K. Yoshimura, M. Shibata, N. Ohura, T. Fukuda, T. Sato, K. Sekine, S. Kato, M. Isshiki, T. Fujita, M. Kobayashi, K. Kawamura, H. Masuda, A. Kamiya and J. Ando: Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nature Medicine, 12(1), 133-7 (2006) (Pubitemid 43050088)
50. U. Lalo, Y. Pankratov, S. P. Wichert, M. J. Rossner, R. A. North, F. Kirchhoff and A. Verkhratsky: P2X1 and P2X5 subunits form the functional P2X receptor in mouse cortical astrocytes. J Neurosci, 28(21), 5473-80 (2008)
51. M. Ryten, P. M. Dunn, J. T. Neary and G. Burnstock: ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells. J Cell Biol, 158(2), 345-55 (2002)
52. Y. Shigematsu, Y. Shimoda and M. Kaneda: Distribution of immunoreactivity for P2X3, P2X5, and P2X6-purinoceptors in mouse retina. J Mol Histol, 38(4), 369-71 (2007) (Pubitemid 47106908)
53. Q. Yu, Z. Zhao, J. Sun, W. Guo, J. Fu, G. Burnstock, C. He and Z. Xiang: Expression of P2X6 receptors in the enteric nervous system of the rat gastrointestinal tract. Histochem Cell Biol, 133(2), 177-88 (2010)
54. T. T. Schwindt, C. A. Trujillo, P. D. Negraes, C. Lameu and H. Ulrich: Directed Differentiation of Neural Progenitors into Neurons Is Accompanied by Altered Expression of P2X Purinergic Receptors. Journal of Molecular Neuroscience (2010)
55. M. Solle, J. Labasi, D. G. Perregaux, E. Stam, N. Petrushova, B. H. Koller, R. J. Griffiths and C. A. Gabel: Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem, 276(1), 125-32 (2001) (Pubitemid 32050297)
56. H. Z. Ke, H. Qi, A. F. Weidema, Q. Zhang, N. Panupinthu, D. T. Crawford, W. A. Grasser, V. M. Paralkar, M. Li, L. P. Audoly, C. A. Gabel, W. S. Jee, S. J. Dixon, S. M. Sims and D. D. Thompson: Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Molecular Endocrinology, 17(7), 1356-67 (2003) (Pubitemid 36819956)
57. X. Zhang, Y. Chen, C. Wang and L. Y. Huang: Neuronal somatic ATP release triggers neuron-satellite glial cell communication in dorsal root ganglia. Proc Natl Acad Sci U S A, 104(23), 9864-9 (2007) (Pubitemid 47175357)
58. I. Novak, I. M. Jans and L. Wohlfahrt: Effect of P2X7 receptor knockout on exocrine secretion of pancreas, salivary glands and lacrimal glands. J Physiol (2010)
59. B. Hechler, N. Lenain, P. Marchese, C. Vial, V. Heim, M. Freund, J. P. Cazenave, M. Cattaneo, Z. M. Ruggeri, R. Evans and C. Gachet: A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med, 198(4), 661-7 (2003) (Pubitemid 37040400)
60. M. Tsuda, Y. Shigemoto-Mogami, S. Koizumi, A. Mizokoshi, S. Kohsaka, M. W. Salter and K. Inoue: P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature, 424(6950), 778-83 (2003) (Pubitemid 37021707)
61. I. P. Chessell, J. P. Hatcher, C. Bountra, A. D. Michel, J. P. Hughes, P. Green, J. Egerton, M. Murfin, J. Richardson, W. L. Peck, C. B. Grahames, M. A. Casula, Y. Yiangou, R. Birch, P. Anand and G. N. Buell: Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain, 114(3), 386-96 (2005) (Pubitemid 40385877)
62. Y. X. Chu, Y. Zhang, Y. Q. Zhang and Z. Q. Zhao: Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses. Brain, Behavior, & Immunity (2010)
63. R. G. Goncalves, L. Gabrich, A. Rosario, Jr., C. M. Takiya, M. L. Ferreira, L. B. Chiarini, P. M. Persechini, R. Coutinho-Silva and M. Leite, Jr.: The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. Kidney Int, 70(9), 1599-606 (2006) (Pubitemid 44606995)
64. G. Burnstock: Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov, 7(7), 575-90 (2008) (Pubitemid 351927723)
65. W. Fischer and U. Krugel: P2Y receptors: focus on structural, pharmacological and functional aspects in the brain. Curr Med Chem, 14(23), 2429-55 (2007) (Pubitemid 47618033)
66. V. Vallon: P2 receptors in the regulation of renal transport mechanisms. Am J Physiol Renal Physiol, 294(1), F10-27 (2008)
67. S. J. Mundell, J. F. Barton, M. B. Mayo-Martin, A. R. Hardy and A. W. Poole: Rapid resensitization of purinergic receptor function in human platelets. J Thromb Haemost, 6(8), 1393-404 (2008) (Pubitemid 352022551)
68. D. M. Scott, R. M. Norwood and D. Parra: P2Y12 inhibitors in cardiovascular disease: focus on prasugrel. Annals of Pharmacotherapy, 43(1), 64-76 (2009)
69. G. Burnstock: Purinergic receptors and pain. Curr Pharm Des, 15(15), 1717-35 (2009)
70. G. Villa, M. Fumagalli, C. Verderio, M. P. Abbracchio and S. Ceruti: Expression and contribution of satellite glial cells purinoceptors to pain transmission in sensory ganglia: an update. Neuron Glia Biol, 6(1), 31-42 (2010)
71. J. Stagg and M. J. Smyth: Extracellular adenosine triphosphate and adenosine in cancer. Oncogene (2010)
72. K. Varani, M. Padovan, M. Govoni, F. Vincenzi, F. Trotta and P. A. Borea: The role of adenosine receptors in rheumatoid arthritis. Autoimmun Rev (2010)
73. J. Reutershan, I. Vollmer, S. Stark, R. Wagner, K. C. Ngamsri and H. K. Eltzschig: Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-inducedPMN trafficking into the lungs. FASEB J, 23(2), 473-82 (2009)
74. J. L. Chunn, J. G. Molina, T. Mi, Y. Xia, R. E. Kellems and M. R. Blackburn: Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J Immunol, 175(3), 1937-46 (2005) (Pubitemid 41023101)
75. C. X. Sun, H. Zhong, A. Mohsenin, E. Morschl, J. L. Chunn, J. G. Molina, L. Belardinelli, D. Zeng and M. R. Blackburn: Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest, 116(8), 2173-2182 (2006) (Pubitemid 44162326)
76. B. Hocher: Adenosine A1 receptor antagonists in clinical research and development. Kidney Int, 78(5), 438-45 (2010)
77. D. S. Ponnoth, A. Nadeem, S. Tilley and S. J. Mustafa: Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. Am J Physiol Heart Circ Physiol, 299(1), H81-7 (2010)
78. K. C. Ngamsri, R. Wagner, I. Vollmer, S. Stark and J. Reutershan: Adenosine Receptor A1 Regulates Polymorphonuclear Cell Trafficking and Microvascular Permeability in Lipopolysaccharide-Induced Lung Injury. J Immunol (2010)
79. N. A. Sowa, M. K. Voss and M. J. Zylka: Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation. Mol Pain, 6, 20 (2010)
80. N. Goldman, M. Chen, T. Fujita, Q. Xu, W. Peng, W. Liu, T. K. Jensen, Y. Pei, F. Wang, X. Han, J. F. Chen, J. Schnermann, T. Takano, L. Bekar, K. Tieu and M. Nedergaard: Adenosine A1 receptors mediate local antinociceptive effects of acupuncture. Nature Neuroscience, 13(7), 883-8 (2010)
81. H. M. Brothers, Y. Marchalant and G. L. Wenk: Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neurosci Lett, 480(2), 97-100 (2010)
82. F. P. Nascimento, S. M. Figueredo, R. Marcon, D. F. Martins, S. J. Macedo, Jr., D. A. Lima, R. C. Almeida, R. M. Ostroski, A. L. Rodrigues and A. R. Santos: Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways. J Pharmacol Exp Ther, 334(2), 590-8 (2010)
83. S. S. Dai, Y. G. Zhou, W. Li, J. H. An, P. Li, N. Yang, X. Y. Chen, R. P. Xiong, P. Liu, Y. Zhao, H. Y. Shen, P. F. Zhu and J. F. Chen: Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury. J Neurosci, 30(16), 5802-10 (2010)
84. H. Wang, W. Zhang, R. Tang, C. Zhu, C. Bucher, B. R. Blazar, J. G. Geng, C. Zhang, J. Linden, C. Wu and Y. Huo: Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein Edeficient mice. Arterioscler Thromb Vasc Biol, 30(5), 915-22 (2010)
85. K. L. Wallace and J. Linden: Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood (2010)
86. S. P. Buira, J. L. Albasanz, G. Dentesano, J. Moreno, M. Martin, I. Ferrer and M. Barrachina: DNA methylation regulates adenosine A(2A) receptor cell surface expression levels. J Neurochem, 112(5), 1273-85 (2010)
87. M. V. Sitkovsky and A. Ohta: The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol, 26(6), 299-304 (2005) (Pubitemid 40732662)
88. H. K. Eltzschig, J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson and S. P. Colgan: Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med, 198(5), 783-96 (2003) (Pubitemid 37087777)
89. T. Kong, K. A. Westerman, M. Faigle, H. K. Eltzschig and S. P. Colgan: HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J, 20(13), 2242-50 (2006) (Pubitemid 44953854)
90. M. A. Pettengill, V. W. Lam and D. M. Ojcius: The danger signal adenosine induces persistence of chlamydial infection through stimulation of A2b receptors. PLoS One, 4(12), e8299 (2009)
91. U. Schingnitz, K. Hartmann, C. F. Macmanus, T. Eckle, S. Zug, S. P. Colgan and H. K. Eltzschig: Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J Immunol, 184(9), 5271-9 (2010)
92. B. Csoka, Z. H. Nemeth, P. Rosenberger, H. K. Eltzschig, Z. Spolarics, P. Pacher, Z. Selmeczy, B. Koscso, L. Himer, E. S. Vizi, M. R. Blackburn, E. A. Deitch and G. Hasko: A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation. J Immunol, 185(1), 542-50 (2010)
93. D. Baram, O. Dekel, Y. A. Mekori and R. Sagi-Eisenberg: Activation of mast cells by trimeric G protein Gi3; coupling to the A3 adenosine receptor directly and upon T cell contact. J Immunol, 184(7), 3677-88 (2010)
94. D. van der Hoeven, E. T. Gizewski and J. A. Auchampach: Activation of the A(3) adenosine receptor inhibits fMLP-induced Rac activation in mouse bone marrow neutrophils. Biochem Pharmacol, 79(11), 1667-73 (2010)
95. K. Barczyk, J. Ehrchen, K. Tenbrock, M. Ahlmann, J. Kneidl, D. Viemann and J. Roth: Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. Blood, 116(3), 446-55 (2010)
96. L. Antonioli, M. Fornai, R. Colucci, O. Awwad, N. Ghisu, M. Tuccori, F. Da Settimo, C. La Motta, G. Natale, E. Duranti, A. Virdis and C. Blandizzi: The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors. J Pharmacol Exp Ther (2010)
97. L. M. Gazoni, D. M. Walters, E. B. Unger, J. Linden, I. L. Kron and V. E. Laubach: Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury. Journal of Thoracic & Cardiovascular Surgery, 140(2), 440-6 (2010)
98. E. Morschl, J. G. Molina, J. B. Volmer, A. Mohsenin, R. S. Pero, J. S. Hong, F. Kheradmand, J. J. Lee and M. R. Blackburn: A3 adenosine receptor signaling influences pulmonary inflammation and fibrosis. American Journal of Respiratory Cell & Molecular Biology, 39(6), 697-705 (2008)
99. R. Zaynagetdinov, S. Ryzhov, A. E. Goldstein, H. Yin, S. V. Novitskiy, K. Goleniewska, V. V. Polosukhin, D. C. Newcomb, D. Mitchell, E. Morschl, Y. Zhou, M. R. Blackburn, R. S. Peebles, Jr., I. Biaggioni and I. Feoktistov: Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice. American Journal of Respiratory Cell & Molecular Biology, 42(5), 564-71 (2010)
100. M. Kronlage, J. Song, L. Sorokin, K. Isfort, T. Schwerdtle, J. Leipziger, B. Robaye, P. B. Conley, H. C. Kim, S. Sargin, P. Schon, A. Schwab and P. J. Hanley: Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal, 3(132), ra55 (2010)
101. C. Marques-da-Silva, G. Burnstock, D. M. Ojcius and R. Coutinho-Silva: Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Immunobiology (2010)
102. S. Hagiwara, H. Iwasaka, A. Hasegawa, M. Oyama, R. Imatomi, T. Uchida and T. Noguchi: Adenosine Diphosphate Receptor Antagonist Clopidogrel Sulfate Attenuates Lps-Induced Systemic Inflammation in a Rat Model. Shock (2010)
103. L. Franchi, T. Eigenbrod, R. Munoz-Planillo and G. Nunez: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol, 10(3), 241-7 (2009)
104. A. Babelova, K. Moreth, W. Tsalastra-Greul, J. Zeng-Brouwers, O. Eickelberg, M. F. Young, P. Bruckner, J. Pfeilschifter, R. M. Schaefer, H. J. Grone and L. Schaefer: Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem, 284(36), 24035-48 (2009)
105. G. Correa, C. Marques da Silva, A. C. de Abreu Moreira-Souza, R. C. Vommaro and R. Coutinho-Silva: Activation of the P2X(7) receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages. Microbes Infect, 12(6), 497-504 (2010)
106. L. Ulmann, H. Hirbec and F. Rassendren: P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J, 29(14), 2290-300 (2010)
107. E. Bulanova and S. Bulfone-Paus: P2 receptormediated signaling in mast cell biology. Purinergic Signal, 6(1), 3-17 (2010)
108. Y. Chen, Y. Yao, Y. Sumi, A. Li, U. K. To, A. Elkhal, Y. Inoue, T. Woehrle, Q. Zhang, C. Hauser and W. G. Junger: Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci Signal, 3(125), ra45 (2010)
109. F. Grassi: Purinergic control of neutrophil activation. J Mol Cell Biol, 2(4), 176-7 (2010)
110. T. Kobayashi, H. Kouzaki and H. Kita: Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP. J Immunol, 184(11), 6350-8 (2010)
111. W. C. Sun, L. J. Berghaus, J. N. Moore, D. J. Hurley, M. L. Vandenplas, R. Thompson and J. Linden: Lipopolysaccharide and TNF-alpha modify adenosine A(2A) receptor expression and function in equine monocytes. Veterinary Immunology & Immunopathology, 135(3-4), 289-95 (2010)
112. R. Chavez-Valdez, M. Wills-Karp, R. Ahlawat, E. A. Cristofalo, A. Nathan and E. B. Gauda: Caffeine modulates TNF-alpha production by cord blood monocytes: the role of adenosine receptors. Pediatric Research, 65(2), 203-8 (2009)
113. R. Rizzo, D. Ferrari, L. Melchiorri, M. Stignani, S. Gulinelli, O. R. Baricordi and F. Di Virgilio: Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G from human monocytes. J Immunol, 183(7), 4302-11 (2009)
114. F. Ben Yebdri, F. Kukulski, A. Tremblay and J. Sevigny: Concomitant activation of P2Y(2) and P2Y(6) receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion. Eur J Immunol, 39(10), 2885-94 (2009)
115. G. D. Liu, J. Q. Ding, Q. Xiao and S. D. Chen: P2Y6 receptor and immunoinflammation. Neurosci Bull, 25(3), 161-4 (2009)
116. L. Liu, J. Zou, X. Liu, L. H. Jiang and J. Li: Inhibition of ATP-induced macrophage death by emodin viaantagonizing P2X7 receptor. Eur J Pharmacol, 640(1-3), 15-9 (2010)
117. M. P. Lees, S. J. Fuller, R. McLeod, N. R. Boulter, C. M. Miller, A. M. Zakrzewski, E. J. Mui, W. H. Witola, J. J. Coyne, A. C. Hargrave, S. E. Jamieson, J. M. Blackwell, J. S. Wiley and N. C. Smith: P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J Immunol, 184(12), 7040-6 (2010)
118. A. K. Sharma, V. E. Laubach, S. I. Ramos, Y. Zhao, G. Stukenborg, J. Linden, I. L. Kron and Z. Yang: Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury. Journal of Thoracic & Cardiovascular Surgery, 139(2), 474-82 (2010)
119. A. Ohta, M. Madasu, R. Kini, M. Subramanian, N. Goel and M. Sitkovsky: A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. J Immunol, 183(9), 5487-93 (2009)
120. M. V. Sitkovsky: T regulatory cells: hypoxiaadenosinergic suppression and re-direction of the immune response. Trends Immunol, 30(3), 102-8 (2009)
121. R. Sluyter, J. A. Barden and J. S. Wiley: Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res, 304(2), 231-6 (2001) (Pubitemid 32448989)
122. C. M. Cascabulho, R. F. Menna-Barreto, R. Coutinho-Silva, P. M. Persechini and A. Henriques-Pons: P2X7 modulatory web in Trypanosoma cruzi infection. Parasitol Res, 103(4), 829-38 (2008)
123. F. Di Virgilio, S. Ceruti, P. Bramanti and M. P. Abbracchio: Purinergic signalling in inflammation of the central nervous system. Trends in Neurosciences, 32(2), 79-87 (2009)
124. I. Pineau and S. Lacroix: Endogenous signals initiating inflammation in the injured nervous system. Glia, 57(4), 351-61 (2009) d
125. J. F. Chen and F. Pedata: Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors. Curr Pharm Des, 14(15), 1490-9 (2008) (Pubitemid 351997814)
126. H. V. Nobre, Jr., G. M. Cunha, L. M. de Vasconcelos, H. I. Magalhaes, R. N. Oliveira Neto, F. D. Maia, M. O. de Moraes, L. K. Leal and G. S. Viana: Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells. Neurochemistry International, 56(1), 51-8 (2010)
127. A. G. Orr, A. L. Orr, X. J. Li, R. E. Gross and S. F. Traynelis: Adenosine A(2A) receptor mediates microglial process retraction. Nature Neuroscience, 12(7), 872-8 (2009)
128. N. D'Ambrosi, P. Finocchi, S. Apolloni, M. Cozzolino, A. Ferri, V. Padovano, G. Pietrini, M. T. Carri and C. Volonte: The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J Immunol, 183(7), 4648-56 (2009)
129. S. D. Skaper, P. Debetto and P. Giusti: The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J, 24(2), 337-45 (2010)
130. M. Monif, C. A. Reid, K. L. Powell, M. L. Smart and D. A. Williams: The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J Neurosci, 29(12), 3781-91 (2009)
131. Y. Gu, Y. Chen, X. Zhang, G. W. Li, C. Wang and L. Y. Huang: Neuronal soma-satellite glial cell interactions in sensory ganglia and the participation of purinergic receptors. Neuron Glia Biol, 6(1), 53-62 (2010)
132. P. Ballerini, P. Di Iorio, R. Ciccarelli, F. Caciagli, A. Poli, A. Beraudi, S. Buccella, I. D'Alimonte, M. D'Auro, E. Nargi, P. Patricelli, D. Visini and U. Traversa: P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia. Int J Immunopathol Pharmacol, 18(2), 255-68 (2005) (Pubitemid 40825888)
133. E. Avignone, L. Ulmann, F. Levavasseur, F. Rassendren and E. Audinat: Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J Neurosci, 28(37), 9133-44 (2008)
134. L. Narcisse, E. Scemes, Y. Zhao, S. C. Lee and C. F. Brosnan: The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes. Glia, 49(2), 245-58 (2005) (Pubitemid 40188503)
135. G. A. Weisman, M. Wang, Q. Kong, N. E. Chorna, J. T. Neary, G. Y. Sun, F. A. Gonzalez, C. I. Seye and L. Erb: Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes. Molecular Neurobiology, 31(1-3), 169-83 (2005) (Pubitemid 41271201)
136. K. Inoue, S. Koizumi, A. Kataoka, H. Tozaki-Saitoh and M. Tsuda: P2Y(6)-Evoked Microglial Phagocytosis. International Review of Neurobiology, 85, 159-63 (2009)
137. M. J. Zylka: Needling adenosine receptors for pain relief. Nature Neuroscience, 13(7), 783-4 (2010)
138. M. Tsuda, H. Tozaki-Saitoh and K. Inoue: Pain and purinergic signaling. Brain Res Rev, 63(1-2), 222-32 (2010)
139. M. F. Jarvis: The neural-glial purinergic receptor ensemble in chronic pain states. Trends in Neurosciences, 33(1), 48-57 (2010)
140. G. Burnstock: Purines and sensory nerves. Handb Exp Pharmacol(194), 333-92 (2009)
141. G. Dell'Antonio, A. Quattrini, E. Dal Cin, A. Fulgenzi and M. E. Ferrero: Antinociceptive effect of a new P(2Z)/P2X7 antagonist, oxidized ATP, in arthritic rats. Neurosci Lett, 327(2), 87-90 (2002) (Pubitemid 34722414)
142. G. Dell'Antonio, A. Quattrini, E. D. Cin, A. Fulgenzi and M. E. Ferrero: Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP. Arthritis Rheum, 46(12), 3378-85 (2002) (Pubitemid 35453550)
143. A. Fulgenzi, G. Dell'Antonio, C. Foglieni, E. Dal Cin, P. Ticozzi, J. S. Franzone and M. E. Ferrero: Inhibition of chemokine expression in rat inflamed paws by systemic use of the antihyperalgesic oxidized ATP. BMC Immunol, 6, 18 (2005)
144. A. Fulgenzi, P. Ticozzi, C. A. Gabel, G. Dell'Antonio, A. Quattrini, J. S. Franzone and M. E. Ferrero: Periodate oxidized ATP (oATP) reduces hyperalgesia in mice: involvement of P2X7 receptors and implications for therapy. Int J Immunopathol Pharmacol, 21(1), 61-71 (2008) (Pubitemid 351501002)
145. C. Matute, I. Torre, F. Perez-Cerda, A. Perez-Samartin, E. Alberdi, E. Etxebarria, A. M. Arranz, R. Ravid, A. Rodriguez-Antiguedad, M. Sanchez-Gomez and M. Domercq: P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci, 27(35), 9525-33 (2007) (Pubitemid 47358223)
146. P. Honore, D. Donnelly-Roberts, M. Namovic, C. Zhong, C. Wade, P. Chandran, C. Zhu, W. Carroll, A. Perez-Medrano, Y. Iwakura and M. F. Jarvis: The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice. Behavioural Brain Research, 204(1), 77-81 (2009)
147. C. N. Wilson, A. Nadeem, D. Spina, R. Brown, C. P. Page and S. J. Mustafa: Adenosine receptors and asthma. Handb Exp Pharmacol(193), 329-62 (2009)
148. M. Caruso, K. Varani, G. Tringali and R. Polosa: Adenosine and adenosine receptors: their contribution to airway inflammation and therapeutic potential in asthma. Curr Med Chem, 16(29), 3875-85 (2009)
149. A. Ohta and M. Sitkovsky: The adenosinergic immunomodulatory drugs. Curr Opin Pharmacol, 9(4), 501-6 (2009)
150. A. Kalda, L. Yu, E. Oztas and J. F. Chen: Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease. J Neurol Sci, 248(1-2), 9-15 (2006) (Pubitemid 44647288)
151. R. A. Cunha and P. M. Agostinho: Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis, 20 Suppl 1, S95-116 (2010)
152. S. Cicko, M. Lucattelli, T. Muller, M. Lommatzsch, G. De Cunto, S. Cardini, W. Sundas, M. Grimm, R. Zeiser, T. Durk, G. Zissel, J. M. Boeynaems, S. Sorichter, D. Ferrari, F. Di Virgilio, J. C. Virchow, G. Lungarella and M. Idzko: Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J Immunol, 185(1), 688-97 (2010)
153. E. Mortaz, G. Folkerts, F. P. Nijkamp and P. A. Henricks: ATP and the pathogenesis of COPD. Eur J Pharmacol, 638(1-3), 1-4 (2010)
154. R. D. Ando, B. Mehesz, K. Gyires, P. Illes and B. Sperlagh: A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain. Br J Pharmacol, 159(5), 1106-17 (2010)
155. W. A. Carroll, D. Donnelly-Roberts and M. F. Jarvis: Selective P2X(7) receptor antagonists for chronic inflammation and pain. Purinergic Signal, 5(1), 63-73 (2009)
156. H. Gunosewoyo and M. Kassiou: P2X purinergic receptor ligands: recently patented compounds. Expert Opin Ther Pat, 20(5), 625-46 (2010)
157. S. A. Friedle, M. A. Curet and J. J. Watters: Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation. Recent Pat CNS Drug Discov, 5(1), 35-45 (2010)
158. T. Takenouchi, K. Sekiyama, A. Sekigawa, M. Fujita, M. Waragai, S. Sugama, Y. Iwamaru, H. Kitani and M. Hashimoto: P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Archivum Immunologiae et Therapiae Experimentalis, 58(2), 91-6 (2010)
159. M. Domercq, A. Perez-Samartin, D. Aparicio, E. Alberdi, O. Pampliega and C. Matute: P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia, 58(6), 730-40 (2010)
160. S. H. Sun: Roles of P2X7 receptor in glial and neuroblastoma cells: the therapeutic Potential of P2X7 receptor antagonists. Molecular Neurobiology, 41(2-3), 351-5 (2010)
161. M. E. Ferrero: A new approach to the inflammatory/autoimmune diseases. Recent Pat Antiinfect Drug Discov, 4(2), 108-13 (2009)
162. R. Akkari, J. C. Burbiel, J. Hockemeyer and C. E. Muller: Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs. Curr Top Med Chem, 6(13), 1375-99 (2006) (Pubitemid 44144923)